Close
ACHEMA MIDDLE EAST 2026

Amgen Announces 2016 Third Quarter Dividend

Amgen announced that its Board of Directors declared a $1.00 per share dividend for the third quarter of 2016.          ...

Gilead Sciences to Release Second Quarter 2016 Financial Results

Gilead Sciences, Inc announced that its second quarter 2016 financial results will be released on Monday, July 25, after the market closes. At 4:30...

Alexion Pharmaceuticals to Report Second Quarter 2016 Results

Alexion Pharmaceuticals Inc announced that the Company will report its financial results for the second quarter ended June 30, 2016 on Thursday, July 28,...

Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals

Bristol-Myers Squibb Company and Cormorant Pharmaceuticals announced today that Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormorant, a private, Stockholm,...

Sanofi Announces Expiration Of HSR Waiting Period Regarding Proposed Acquisition Of Medivation

Sanofi announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) in connection with Sanofi’s intent to acquire...

Dr. Reddy’s to acquire product portfolio from TEVA Pharmaceutical for US Market

Dr. Reddy’s Laboratories has entered into a definitive agreement with Teva and affiliate of Allergan plc to acquire  portfolio of eight Abbreviated New Drug...

Bristol-Myers Squibb to Announce Results for Second Quarter 2016

Bristol-Myers Squibb Company will announce results for the second quarter of 2016 on Thursday, July 28, 2016. During a conference call at 10:30 a.m....

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...